Diabetes mellitus in percutaneous coronary intervention: greater awareness is needed to predict and prevent poor outcomes.
Department of Cardiology, Cardiac Renal Centre, Cork University Hospital, Wilton, Cork, Ireland.
Grace
G
O'Carroll
Peter P
PP
Kearney
D000925:Anticoagulants / Q000009:adverse effects*; D000991:Antithrombins / Q000009:adverse effects*; D003324:Coronary Artery Disease / Q000628:therapy*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000628:therapy*; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D015607:Stents
D000925:Anticoagulants; D000991:Antithrombins; D007004:Hypoglycemic Agents; D007328:Insulin; D010975:Platelet Aggregation Inhibitors